July 13, 2022
July 13, 2022 – The FDA has granted emergency use authorization to Novavax’s COVID-19 vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus in adults.
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health
July 8, 2022
July 8, 2022 – Krystexxa® (pegloticase – Horizon Therapeutics) has received an expanded indication for co-administration with methotrexate to treat chronic gout
July 8, 2022
July 8, 2022 – Comirnaty® (COVID-19 vaccine, mRNA – Pfizer and BioNTech) is now FDA approved for use in adolescents who are 12-15 years old. This age group
July 6, 2022
July 6, 2022 – Mylan Pharmaceuticals has recalled one batch of Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3mL prefilled pens. The product
July 6, 2022
July 6, 2022 – The U.S. FDA has revised emergency use authorization (EAU) for Pfizer’s PaxlovidTM (nirmatrelvir and ritonavir) to allow state-licensed pharmacists
June 30, 2022
June 30, 2022 – The U.S. FDA has issued a safety warning for Secura Bio’s Copiktra® (duvelisib), a treatment for chronic lymphocytic leukemia (CLL) and small
June 29, 2022
June 29, 2022 – Based on recent data, the U.S. FDA has revised emergency use authorization (EUA) for
AstraZeneca’s vuseldTM (tixagevimab co-packaged with cilgavimab)
June 27, 2022
June 27, 2022 – The U.S. FDA has approved Qsymia® (phentermine/topiramate extended-release capsules – Vivus) to provide chronic weight management in pediatric